People living with cancer urgently need action on expanded access to precision therapies
Over the past two decades, our ability to rapidly obtain genomic information on an individual and their cancer has led to a dramatic shift in how we can diagnose, treat, monitor and prevent cancer, leading to an era of precision oncology.
With this expanded knowledge of cancer there are several promising treatments that can specifically target the drivers of an individual’s cancer, that are already under review through Australia’s health technology assessment process. Too many people living with cancer in Australia still don’t have access; and they can’t afford to wait.
Click the button below to read the full position statement:
View Position Statement